Skip to Main Content
CWRU Links

School of
Medicine

Pathology

Faculty

Faculty

Howard Meyerson

Howard Meyerson

Associate Professor, Pathology, CWRU School of Medicine Director, Flow Cytometry, UH Case Medical Center Program Director, Hematopathology, UH Case Medical Center

howard.meyerson@case.edu (216) 844-1848 (o)
YearEducation
1983 B.A. with Distinction, Biochemistry and Molecular Biology, Northwestern University, Evanston, Illinois
1987 M.D., Case Western Reserve University, Cleveland, Ohio
1987-1990 Anatomic Pathology Resident, Department of Pathology, Case Western Reserve University and University Hospitals of Cleveland
1990-1991 Immunopathology Fellow, Department of Pathology, Case Western Reserve University and University Hospitals of Cleveland
1991-1994 NIH Postdoctoral Fellow National Research Service Award
1991-1993 Clinical Pathology Resident, Department of Pathology, Case Western Reserve University and University Hospitals of Cleveland
1994-1996 Hematopathology Fellow, Department of Pathology, Case Western Reserve University and University Hospitals of Cleveland
1996-1997 Instructor in Pathology, Department of Pathology, Case Western Reserve University
1997-present Assistant Professor, Department of Pathology, Case Western Reserve University
1998-present Director of Hematopathology, University Hospitals of Cleveland
1996-2000 Director, Clinical Pathology Resident Training, University Hospitals of Cleveland
2000-present Director of Flow Cytometry, University Hospitals of Cleveland

Research summary

My work has focused on the analysis and classification of hematopoietic neoplasms and the flow cytometric analysis of these disorders. I am in involved in collaborative work using high resolution phenotypic analysis- amplification staining techniques for the evaluation of these neoplasms. I also am involved in several collaborations in the analysis of immune cell subsets in a variety of disorders and therapeutic interventions.

Meyerson HJ, Huang JH, Fayen JD, Getty R, Greenspan NS, Tykocinski ML (1996) Functional dissociation of CD8alpha's immunoglobulin homologue and connecting peptide domains. J Immunol 156,574-584.

Meyerson HJ, Farhi D, Rosenthal N (1998) Transient increase in blasts mimicking AML or MDS following growth factor therapy. Am J Clin Path 109, 675-681.

Chen A, Meyerson HJ, Salvekar A, Tykocinski ML (1998) Non-glycosylated human B7-1 (CD80) retains the capacity to bind to its counter-receptors. FEBS Lett 428, 127-134.

Antall PM, Meyerson HJ, Kaplan D, Venglarcik J, Hostoffer RW (1999) Selective anti-polysaccharide antibody deficiency associated with peripheral blood CD5 positive B cell predominance. J Allergy Clin Immunol 103, 637.

Patki AH, Purvis SF, Meyerson HJ, Lederman MM (1999) Lymphocyte proliferation assays may underestimate antigen responsiveness in human immunodeficiency virus infection. Clin Immunol 93, 245-249.

Koc ON, Gerson SL, Cooper BW, Laughlin M, Meyerson H, Kutteh L, Fox RM, Szekely EM, Tainer N, Lazarus HM (2000). Randomized crossover trial of progenitor cell mobilization: high dose cyclophosphamide plus G-CSF versus GM-CSF plus G-CSF. J Clin Oncol 18, 1824-1830

Edelman J, Meyerson HJ (2000) Diminished CD3 expression is useful for detecting and enumerating Sezary cells. Am J Clin Path 114, 467-477.

Salkowitz J, Purvis S, Meyerson H, Zimmerman P, O'Brien T, Aledort L, Eyster ME, Hilgartner M, Kessler C, Konkle B, White G, Goedert J, Lederman M (2001) Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol 98, 200-211.

Villella A, Picard C, Jouanguy E, Popko S, Meyerson H, Abughali N, Casanova J-L, Hostoffer RW (2001) Recurrent mycobacterial avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics 107, e47

Kaplan D, Meyerson HJ, Lewandowski C (2001) High resolution immunophenotypic analysis of chronic lymphocytic leukemia cells by enzymatic amplification staining (EAS). Am J Clin Path 116, 429-436.